As of June 2023 Agenus has a market cap of $0.55 Billion. This makes Agenus the world's 5378th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2023 | $0.55 B | -24.17% |
2022 | $0.73 B | -11.54% |
2021 | $0.82 B | 32.62% |
2020 | $0.62 B | 11.17% |
2019 | $0.56 B | 96.41% |
2018 | $0.28 B | -12.56% |
2017 | $0.32 B | -9.02% |
2016 | $0.35 B | -8.48% |
2015 | $0.39 B | 57.52% |
2014 | $0.24 B | 159.49% |
2013 | $95.95 M | -4.87% |
2012 | $0.10 B | 135.06% |
2011 | $42.91 M | -61.94% |
2010 | $0.11 B | 96.27% |
2009 | $57.44 M | 80.58% |
2008 | $31.8 M | -67.21% |
2007 | $97 M | 15.63% |
2006 | $83.89 M | -61.34% |
2005 | $0.21 B | -52.91% |
2004 | $0.46 B | 2.82% |
2003 | $0.44 B | 32.18% |
2002 | $0.33 B | -28.74% |
2001 | $0.47 B |
On Jun 1st, 2023 the market cap of Agenus was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $401.60 B | 72,299.21% | ๐บ๐ธ USA |
![]() Merck MRK | $281.47 B | 50,643.05% | ๐บ๐ธ USA |
![]() Bristol-Myers Squibb BMY | $135.88 B | 24,396.09% | ๐บ๐ธ USA |
![]() GlaxoSmithKline GSK | $69.32 B | 12,397.61% | ๐ฌ๐ง UK |
![]() Celldex Therapeutics CLDX | $1.51 B | 173.70% | ๐บ๐ธ USA |